Zantac / Ranitidine (NDMA Cancer) Lawsuit in Nebraska

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Nebraska imposes a 4-year statute of limitations for product liability claims (Neb. Rev. Stat. § 25-224) and applies the discovery rule for latent pharmaceutical injuries. Nebraska courts apply Daubert reliability standards for expert testimony under Neb. Rev. Stat. § 27-702. Nebraska's 4-year SOL is among the more favorable in the Midwest.

4 years from date of cancer diagnosis discovery (Daubert expert standard)

Nebraska Data

Exposure in Nebraska

Source: U.S. Census Bureau 2024

Source: Neb. Rev. Stat. § 25-224

Medical Resources

Clinics & Specialists in Nebraska

Fred & Pamela Buffett Cancer Center (UNMC)

CHI Health St. Francis Cancer Center

Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview